Los Angeles Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-22,844
| Closed | -$397K | – | 1453 |
|
|
2022
Q1 | $397K | Hold |
22,844
| – | – | ﹤0.01% | 1133 |
|
|
2021
Q4 | $500K | Hold |
22,844
| – | – | ﹤0.01% | 1010 |
|
|
2021
Q3 | $437K | Buy |
22,844
+5,300
| +30% | +$101K | ﹤0.01% | 1121 |
|
|
2021
Q2 | $301K | Buy |
+17,544
| New | +$301K | ﹤0.01% | 1384 |
|
|
2020
Q4 | – | Sell |
-15,392
| Closed | -$227K | – | 1546 |
|
|
2020
Q3 | $227K | Sell |
15,392
-33,628
| -69% | -$496K | ﹤0.01% | 1361 |
|
|
2020
Q2 | $726K | Buy |
49,020
+19,300
| +65% | +$286K | ﹤0.01% | 970 |
|
|
2020
Q1 | $326K | Buy |
+29,720
| New | +$326K | ﹤0.01% | 1027 |
|
|
2018
Q3 | – | Sell |
-70,140
| Closed | -$492K | – | 1483 |
|
|
2018
Q2 | $492K | Buy |
70,140
+56,988
| +433% | +$400K | ﹤0.01% | 1139 |
|
|
2018
Q1 | $187K | Sell |
13,152
-38,287
| -74% | -$544K | ﹤0.01% | 1273 |
|
|
2017
Q4 | $451K | Buy |
51,439
+37,549
| +270% | +$329K | ﹤0.01% | 1079 |
|
|
2017
Q3 | $163K | Buy |
+13,890
| New | +$163K | ﹤0.01% | 1264 |
|